Given that both SOCS3 and IL6R play a key role in the IL-6 signaling pathway, the main aim of the current study was to investigate whether the methylation patterns of SOCS3 and IL6R promoters are associated with the morbidity and severity of RA. This evidence concerns the gene IL6 and rheumatoid arthritis.